
Abuse Deterrent Technologies
Striving to attain certain physico-chemical clinical studies outcomes in order to consider our products to be considered abuse deterrent.
Abuse Deterrent Technologies
We suggest that our technologies provide the following physico-chemical properties in order for our products to be considered abuse deterrent:
- Should be difficult to abuse through crushing, chewing or licking
- Release of opioid is likely to be slower or not instantaneous in a range of beverages and solvents
- Should not "dose dump", or instantaneously release the entire dose of opioid, in the presence of ethanol over a range of concentrations
- When pulverized and reduced to particles, should be difficult and time consuming to syringe or inject in the form and volume suitable for intravenous administration
- When pulverized or reduced to particles, contains an irritant which should make it difficult or inefficient to snort or inhale
- Release of opioid should be insignificant or inefficient via heating and vaporization
- Extraction of opioid which has been microwaved should be difficult or inefficient

Product Pipeline
See our technology in action. Our product portfolio includes both new products, which follow a New Drug Application (NDA) 505(b)(2) FDA regulatory pathway, and controlled-release generic products, which follow an Abbreviated New Drug Application (ANDA) pathway.